BioPharma Credit PLC

BPCR:LSE

BioPharma Credit PLC

Actions
  • Price (USD)0.876
  • Today's Change0.00 / 0.00%
  • Shares traded2.40m
  • 1 Year change-8.56%
  • Beta0.2682
Data delayed at least 20 minutes, as of Apr 19 2024 17:21 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue136218104
OPERATING EXPENSES
Cost of revenue total253416
Selling, general and admin. expenses, total1.541.422.49
Depreciation/amortization------
Unusual expense(income)--0.110.18
Other operating expenses, total0.500.400.34
Total operating expense273619
Operating income10818285
Other, net------
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes10818285
Provision for income taxes000
Net income after taxes10818285
Minority interest------
Net income before extra. Items10818285
Total extraordinary items------
Net income10818285
Inc.avail. to common excl. extra. Items10818285
Inc.avail. to common incl. extra. Items10818285
EPS RECONCILIATION
Basic/primary weighted average shares1,3091,3641,374
Basic/primary eps excl. extra items0.080.130.06
Basic/primary eps incl. extra items0.080.130.06
Dilution adjustment------
Diluted weighted average shares1,3091,3641,374
Diluted eps excl. extra items0.080.130.06
Diluted eps incl. extra items0.080.130.06
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.090.070.07
Gross dividend - common stock--17696
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental------
SUPPLEMENTAL INCOME
Depreciation, supplemental------
Total special items--0.110.18
NORMALISED INCOME
Normalized income before taxes10818285
Effect of special items on income taxes--00
Income tax excluding impact of special items000
Normalized income after tax10818285
Normalized income avail. to common10818285
Basic normalized EPS0.080.130.06
Diluted normalized EPS0.080.130.06
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.